Combined Use of Remimazolam and Propofol in total intravenous anesthesia: A Retrospective Analysis

Combined Use of Remimazolam and Propofol - Combined Use of Remimazolam and Propofol

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052431

Enrollment

Registered

2023-10-06

Start date

2023-10-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent general anesthesia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received general anesthesia between May 2022 and May 2023 at Fukushima Medical University hospital, those in which remimazolam and propofol were used for anesthesia maintenance.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Effect-site concentrations of remimazolam and propofol during anesthesia	—

Secondary

Measure	Time frame
Time to recovery of responsiveness	—

Countries

Japan

Contacts

Public ContactShinju Obara

Fukushima Medical University Hospital Anesthesiology, Surgical operation department

masui@fmu.ac.jp0245471111

Outcome results